Billions of people worldwide are at risk from microorganisms transmitted by mosquitoes, ticks, fleas, and other vectors. Due to the complexity of vector-borne pathogen transmission, and the unpredictable nature of insect vectors, vector-borne illnesses are among the most difficult infectious diseases to predict, prevent, and control.

To help support the development of molecular-based assays for pathogen detection or quantification, ATCC is pleased to announce the release of genomic DNA isolated from Babesia microti, and synthetically-derived RNA representing Dengue virus types I-IV.

These ATCC^® Genuine Nucleics can be used for assay development, verification, validation, monitoring of day-to-day test variation, and lot-to-lot performance of molecular-based assays. Moreover, their quantitative format allows for the generation of a standard curve for quantitative PCR (qPCR).

For more information on vector-borne illnesses, or to search for strains and nucleic acids to support your research, please visit us online at www.atcc.org/vectorborne.